In 389 ICU patients with sepsis or septic shock, adding metagenomic sequencing of microbial cell-free DNA to standard microbiology did not significantly improve the primary DOOR/RADAR score at 28 days (3.21 vs 3.49). Some exploratory secondary outcomes improved.
RCTn = 389
Brenner et al. Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial